Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Ebastine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 known ✓ | P35367 | 1/20 | 1.00 |
| ▸ | ADRA1D | P25100 | 2/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 2/20 | 1.00 |
| ▸ | ADRA1B | P35368 | 2/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 1.00 |
| ▸ | MLNR | O43193 | 1/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | EGFR | P00533 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | ERBB2 | P04626 | 1/20 | 1.00 |
| ▸ | FYN | P06241 | 1/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 1.00 |
| ▸ | CHRM4 | P08173 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | ADRB1 | P08588 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | CHRM5 | P08912 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ebastine SCHEMBL25205252 | 0.99 | ADRA1D (0.98) | ADRA1DADRA1AADRA1BNPC1MLNR | |
| Ebastine SCHEMBL2546560 | 0.98 | ADRA1D (0.96) | ADRA1DADRA1AADRA1BNPC1MLNR | |
| SCHEMBL12197484 | 0.97 | CHRM2 (0.94) | ADRA1DADRA1AADRA1BNPC1MLNR | |
| SCHEMBL1362953 | 0.97 | ADRA1D (0.94) | ADRA1DADRA1AADRA1BNPC1MLNR | |
| Ebastine SCHEMBL25228349 | 0.96 | DRD2 (0.93) | ADRA1DADRA1AADRA1BNPC1MLNR | |
| Ebastine SCHEMBL2471948 | 0.96 | ADRA1D (0.93) | ADRA1DADRA1AADRA1BNPC1MLNR | |
| Ebastine SCHEMBL25207151 | 0.95 | ADRA1D (0.91) | ADRA1DADRA1AADRA1BNPC1MLNR | |
| Ebastine SCHEMBL2475732 | 0.95 | ADRA1D (0.91) | ADRA1DADRA1AADRA1BNPC1MLNR | |
| Ebastine SCHEMBL25199696 | 0.95 | ADRA1D (0.91) | ADRA1DADRA1AADRA1BNPC1MLNR | |
| Ebastine SCHEMBL28531760 | 0.95 | ADRA1D (0.91) | ADRA1DADRA1AADRA1BNPC1MLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11104 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-12569451-B2 | Bio-inspired tissue-adhesive hydrogel patch and uses thereof | Cellartgen Inc. (KR) | 2026-03-10 | — | — | US | claimed |
| EP-4691492-A2 | LIQUID COMPOSITIONS | Kenvue Brands LLC (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4691568-A2 | LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF | Eye Therapies, LLC (US) | 2026-02-11 | — | — | EP | claimed |
| US-12478627-B2 | Irsogladine for the treatment of eosinophilic gastrointestinal diseases | EPITHELION SCIENCE BIOTECH, S.L. (ES) | 2025-11-25 | — | — | US | claimed |
| EP-4637824-A1 | METHOD OF PREVENTING AND TREATING ALZHEIMER'S DISEASE AND RELATED DEMENTIAS WITH DRUGS INHIBITING THE INTERACTION BETWEEN 14-3-3G PROTEIN AND HEXOKINASE-1 PROTEIN | BIOVENTURES, LLC (US) | 2025-10-29 | — | — | EP | claimed |
| EP-4630401-A2 | CARBONIC ANHYDRASE ENZYME INHIBITORS AND METHODS OF USE THEREOF | Rutgers, the State University of New Jersey (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4247331-B1 | ORODISPERSIBLE POWDER COMPOSITION COMPRISING AN ANTIHISTAMINE COMPOUND | BIOPHARMA SYNERGIES S L (ES) | 2025-10-08 | — | — | EP | claimed |
| US-20250275951-A1 | DRUGS TARGETING INFLAMMATION FOR THE TREATMENT OF OSTEOARTHRITIS AND OTHER INFLAMMATORY DISEASES | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2025-09-04 | — | — | US | claimed |
| WO-1989010143-A1 | CERTAIN PAF ANTAGONIST ANTIHISTAMINE COMBINATIONS AND METHODS | SCHERING CORPORATION (US) | 1989-11-02 | — | — | WO | claimed |
| EP-0316434-A4 | COUGH/COLD MIXTURES COMPRISING NON-SEDATING ANTIHISTAMINE DRUGS. | SUNSHINE ABRAHAM (US) | 1989-10-16 | — | — | EP | claimed |
| US-4871733-A | WITH NON-STEROIDAL ANTIINFLAMMATORY | ANALGESIC ASSOCIATES (US) | 1989-10-03 | — | — | US | claimed |
| EP-0316434-A1 | COUGH/COLD MIXTURES COMPRISING NON-SEDATING ANTIHISTAMINE DRUGS. | SUNSHINE ABRAHAM (US) | 1989-05-24 | — | — | EP | claimed |
| EP-0311677-A1 | COUGH/COLD MIXTURES COMPRISING NON-SEDATING ANTIHISTAMINE DRUGS. | SUNSHINE ABRAHAM (US) | 1989-04-19 | — | — | EP | claimed |
| WO-1988009656-A1 | COUGH/COLD MIXTURES COMPRISING NON-SEDATING ANTIHISTAMINE DRUGS | SUNSHINE ABRAHAM (US) | 1988-12-15 | — | — | WO | claimed |
| WO-1988008302-A1 | COUGH/COLD MIXTURES COMPRISING NON-SEDATING ANTIHISTAMINE DRUGS | SUNSHINE ABRAHAM (US) | 1988-11-03 | — | — | WO | claimed |
| EP-0134124-B1 | PIPERIDINE DERIVATIVES | FORDONAL, S.A. (ES) | 1987-10-28 | — | — | EP | claimed |
| US-4550116-A | ANTIALLERGENS, CARDIOVASCULAR AND RESPIRATORY DISORDERS | FORDONAL, S.A. (ES) | 1985-10-29 | — | — | US | claimed |
| EP-0134124-A1 | Piperidine derivatives | FORDONAL, S.A. (ES) | 1985-03-13 | — | — | EP | claimed |